Results 211 to 220 of about 36,892 (234)

Multisystem Inflammatory Syndrome in New Zealand Children

Pediatric Infectious Disease Journal, 2023
New Zealand (NZ) initially adopted an elimination approach to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Pre-Omicron variant, the NZ pediatric population was immunologically naïve to SARS-CoV-2. This study, utilizing national data sources, describes the NZ incidence of multisystem inflammatory syndrome in children (MIS-C) following ...
Amanda Taylor, Mavis Duncanson, Bryan Mitchelson, Gabrielle Nuthall, Lesley Voss, Tony Walls, Stuart R. Dalziel, Genevieve Ostring, Emma J. Best   +8 more
openaire   +2 more sources

Clinical features of multisystem inflammatory syndrome in children

Current Opinion in Rheumatology, 2021
Purpose of review To review diagnosis, clinical characteristics and treatment of multisystem inflammatory syndrome in children (MIS-C) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent findings MIS-C emerged in spring 2020 as a hyperinflammatory ...
Jordan E, Roberts, Lauren A, Henderson
openaire   +2 more sources

Early Treatment of Multisystem Inflammatory Syndrome in Children

Pediatrics, 2023
BACKGROUND AND OBJECTIVES Multisystem inflammatory syndrome in children (MIS-C) is a severe hyperinflammatory illness occurring after severe acute respiratory syndrome coronavirus 2 infection. The optimal treatment of MIS-C is unknown, although prior studies have indicated benefits of intravenous immunoglobulin ...
Brian, Jonat, Andrew S, Geneslaw, Christine A, Capone, Sareen, Shah, Lisa, Bartucca, Taylor B, Sewell, Karen P, Acker, Elizabeth, Mitchell, Eva W, Cheung   +8 more
openaire   +2 more sources

Treatment of multisystem inflammatory syndrome in children

World Journal of Pediatrics
Multisystem inflammatory syndrome in children (MIS-C), a relatively uncommon but severe pediatric complication, is associated with coronavirus disease 2019 (COVID-19). A variety of treatment approaches, including intravenous immunoglobulins (IVIGs), glucocorticoids (GCs) and biologic agents, such as anakinra and infliximab, have been described for the ...
Tong, Tong, Yi-Hua, Jin, Min, Wang, Fang-Qi, Gong   +3 more
openaire   +2 more sources

Multisystem inflammatory syndrome in children: A review

Acta Paediatrica
AbstractAimTo comprehensively review the literature on multisystem inflammatory syndrome in children (MIS‐C).MethodsNarrative review of relevant studies published between April 2020 and January 2024.ResultsMIS‐C is a SARS‐CoV‐2‐related hyperinflammatory syndrome developing 2–6 weeks after COVID‐19 in genetically susceptible individuals.
Benvenuto, Simone, Avcin, Tadej, Taddio, Andrea   +2 more
openaire   +3 more sources

Childhood multisystem inflammatory syndrome

Archives of Disease in Childhood, 2020
openaire   +2 more sources

Review of Cardiac Involvement in Multisystem Inflammatory Syndrome in Children

Circulation, 2021
Jane Burns, Adriana Tremoulet, Kevin Friedman   +2 more
exaly  

Single-Cell Meta-Analysis of Neutrophil Activation in Kawasaki Disease and Multisystem Inflammatory Syndrome in Children Reveals Potential Shared Immunological Drivers

Circulation, 2023
Tai-Ming Ko, Chaw-Liang Chang, Jan Vincent Beltran   +2 more
exaly  

Multisystem Inflammatory Syndrome in Children: Survey of Protocols for Early Hospital Evaluation and Management

Journal of Pediatrics, 2021
Adriana Tremoulet, , Michael Kelleman
exaly  

The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19

Cell, 2020
Daniel Eriksson, Lakshmikanth Tadepally, Alessandra Ruggiero   +2 more
exaly